Abstract
In order to study the practicability of rating scales in the regular care of people with epilepsy, indices have been developed and tested on their validity. These indices consist of the Index of Seizures, representing seizure activity, and the Composite Index of Impairment concerning the severity of impairment caused by the seizure type and frequency and the side-effects of anti-epileptic drug treatment. The indices have been applied in a retrospective quantitative evaluation of anti-epileptic drug therapy. The medical records of 250 randomly selected patients registered at an adult out-patient clinic have been reviewed. Their seizures have been classified as generalized tonic-clonic, simple partial and/or complex partial. The distribution of this population according to these indices has been studied, which leads us to the following conclusions:
-
the global indices are valid for clinical application;
-
in 18.6% of the patients studied there was severe impairment and unacceptable seizure control;
-
combined types of seizure are difficult to control;
-
no significant difference is demonstrated between monotherapy and polytherapy regarding the amount of neurotoxicity.
The indices can be determined rapidly and therefore may become valuable aids for the physician in an out-patient clinic to support a decision whether or not to revise current anti-epileptic drug therapy.
Similar content being viewed by others
References
Beghi E, Di Mascio R, Tognoni G. Drug treatment of epilepsy. Outlines, criticism and perspectives. Drugs 1986;31:249–65.
Feinstein AR. Clinimetrics. New Haven: Yale University Press, 1987.
Cramer JA, Mattson RH, Smith DB, et al. A method of quantification for the evaluation of antiepileptic drug therapy. Neurology 1983;33(Suppl 1):26–37.
Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic clonic seizures. N Engl J Med 1985;313:145–51.
Gowers WR. Epilepsy and other chronic convulsive diseases. London: Churchill, 1881.
Reynolds EH. Iatrogenic disorders in epilepsy. In: Williams D, ed. Modern trends in neurology; vol. 5. London: Butterworth, 1970:271–86.
Rwiza HT, Keyser A, Hekster YA, et al. Retrospective analysis of drug treatment in epileptic patients. Pharm Weekbl [Sci] 1989;11(2):50–5.
Anonymous. WHO-International Classification of impairments, disabilities and handicaps. Geneva: World Health Organization, 1980.
Trimble MR. Chronic epilepsy. Its prognosis and management. Chichester: John Wiley & Sons, 1989.
Meldrum BS. Pathophysiology of chronic epilepsy. In: Trimble MR, ed. Chronic epilepsy. Its prognoses and management. Chichester: John Wiley & Sons, 1989:1–11.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wijsman, D.J.P., Hekster, Y.A., Keyser, A. et al. Clinimetrics and epilepsy care. Pharmaceutisch Weekblad Scientific Edition 13, 182–188 (1991). https://doi.org/10.1007/BF01957744
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957744